homehealthcare News

WHO investigating links between cough syrup deaths, considers advice for parents

healthcare | Jan 23, 2023 11:09 PM IST

WHO investigating links between cough syrup deaths, considers advice for parents

Mini

It is in response to several recent incidents of confirmed or suspected contamination of over-the-counter cough syrups in at least seven countries, prompting the WHO to call for action across its 194 member nations to prevent more fatalities.

Recommended Articles

View All

The World Health Organization (WHO) is investigating whether there is any connection between manufacturers whose contaminated cough syrups it has linked to the deaths of more than 300 children in three countries, Reuters reported.
Moreover, the report further said that the WHO has cited “unacceptable levels” of toxins in the products and is seeking more information about the specific raw materials used by six manufacturers in India and Indonesia. However, it has not named any supplier.
Earlier, WHO on Monday made an urgent call to action to countries around the world, urging them to take immediate and concerted action to prevent, detect, and respond to incidents of substandard and falsified medical products.
It is in response to several recent incidents of confirmed or suspected contamination of over-the-counter cough syrups in at least seven countries, prompting the WHO to call for action across its 194 member nations to prevent more fatalities.
As per reports, cough syrups contained significant quantities of diethylene glycol and ethylene glycol, which can be lethal to humans when consumed.
These incidents are not isolated, and WHO is concerned that similar incidents may occur in other countries if immediate action is not taken, it said in a statement.
"These contaminants are toxic chemicals used as industrial solvents and antifreeze agents that can be fatal even taken in small amounts," it continued. These chemicals should never be found in medicines, and the fact that they have been discovered in cough syrups is a cause for serious concern, it added.
Earlier, in response to these incidents, WHO had issued three global medical alerts addressing the situation. The first alert was issued on October 5, 2022, and focused on the outbreak in the Gambia. The second alert was issued on November 6, 2022, and focused on Indonesia. The third alert was issued in January 2023 and focused on Uzbekistan.
WHO is also calling on the pharmaceutical industry to take measures to ensure the quality and safety of their products, and on international organizations to support countries in their efforts to combat substandard and falsified medical products.
-With input from Reuters
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers
    CurrencyCommodities
    CompanyPriceChng%Chng